Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics's Climate Target Data Preview

As of 2023, Innovent Biologics has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Innovent Biologics ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Unit of Other Product (Unlisted) Produced/Manufactured
Copy restricted. Please purchase to unlock this data.
2030

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Innovent Biologics's Greenhouse Gas Emissions Pathways

As of 2023, Innovent Biologics has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Does Innovent Biologics have a target to reduce the emissions from its operations?

As of 2023, Innovent Biologics has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

Innovent Biologics's most ambitious operational target is to reduce these emissions by 10% by 2030, compared to a baseline of 0.014 Metric Tonnes of CO2 equivalent (mtCO2e) per Unit of Other Product (Unlisted) Produced/Manufactured in 2020.

Innovent Biologics has already surpassed its operational emissions reduction target, with 2023 levels falling below the 2030 value, achieving its climate goal ahead of schedule.

Innovent Biologics's Operational (Scope 1+2) Emissions Pathway

202020232030000.010.010.01Current (-61%)Target 2030 (-10%)
Want Full Access to Innovent Biologics's Climate Targets Dataset?
Sign Up